KRENITSKY KEVIN
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to KRENITSKY KEVIN. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| CFOR | President | Purchase | 43,716 | — | — | May 19, 2016 |
| CFOR | President | Purchase | 8,334 | $6.00 | $50,004 | May 8, 2015 |
| 0001488613 | Chief Commercial Officer & SVP | Sale | 70 | $18.75 | $1,313 | Sep 30, 2014 |
| 0001488613 | Chief Commercial Officer & SVP | Sale | 69 | $27.20 | $1,877 | Jun 30, 2014 |
| 0001488613 | Chief Commercial Officer & SVP | Award / Grant | 3,250 | $29.94 | $97,305 | Apr 9, 2014 |
| 0001488613 | Chief Commercial Officer & SVP | Award / Grant | 3,250 | $29.94 | $97,305 | Apr 9, 2014 |
| 0000316253 | President, Enzo Clinical Labs | Award / Grant | 6,000 | — | — | Jan 29, 2010 |
| 0000316253 | President, Enzo Clinical Labs | Purchase | 6,600 | $7.70 | $50,820 | Oct 15, 2009 |